FERRARI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 8.128
AS - Asia 5.245
EU - Europa 3.908
SA - Sud America 840
Continente sconosciuto - Info sul continente non disponibili 437
AF - Africa 130
OC - Oceania 5
Totale 18.693
Nazione #
US - Stati Uniti d'America 7.754
IT - Italia 1.616
VN - Vietnam 1.565
SG - Singapore 1.346
CN - Cina 1.063
BR - Brasile 618
HK - Hong Kong 532
DE - Germania 446
RU - Federazione Russa 406
CA - Canada 274
GB - Regno Unito 215
SE - Svezia 211
IE - Irlanda 200
FR - Francia 175
BD - Bangladesh 152
IN - India 132
UA - Ucraina 97
FI - Finlandia 96
ID - Indonesia 86
NL - Olanda 81
AR - Argentina 78
KR - Corea 70
AT - Austria 68
DK - Danimarca 66
ES - Italia 62
ZA - Sudafrica 53
TR - Turchia 49
MX - Messico 47
PL - Polonia 43
CO - Colombia 40
IQ - Iraq 40
VE - Venezuela 30
JP - Giappone 28
PK - Pakistan 28
EC - Ecuador 26
PH - Filippine 25
SA - Arabia Saudita 24
CH - Svizzera 23
BE - Belgio 18
CL - Cile 18
CZ - Repubblica Ceca 17
LT - Lituania 16
MA - Marocco 16
UZ - Uzbekistan 16
TN - Tunisia 13
JO - Giordania 12
TT - Trinidad e Tobago 12
JM - Giamaica 11
PY - Paraguay 11
ET - Etiopia 10
KE - Kenya 10
MY - Malesia 10
IL - Israele 9
IR - Iran 9
PE - Perù 9
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
EG - Egitto 7
KZ - Kazakistan 7
AL - Albania 6
CR - Costa Rica 6
GR - Grecia 6
NP - Nepal 6
PT - Portogallo 6
RS - Serbia 6
AU - Australia 4
AZ - Azerbaigian 4
BG - Bulgaria 4
HN - Honduras 4
HR - Croazia 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
CY - Cipro 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
TW - Taiwan 2
YE - Yemen 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 18.241
Città #
Ann Arbor 961
Ashburn 833
Singapore 773
Milan 543
San Jose 530
Hong Kong 521
Ho Chi Minh City 449
Hanoi 430
Fairfield 408
Frankfurt am Main 287
Woodbridge 274
Dallas 254
Wilmington 248
Houston 214
Chandler 200
Dublin 192
New York 188
Council Bluffs 171
Seattle 170
Toronto 169
Santa Clara 154
Los Angeles 149
Cambridge 145
Beijing 143
Hefei 135
Rome 133
Chicago 115
Dearborn 93
Jacksonville 84
Princeton 72
Shanghai 70
The Dalles 70
Buffalo 66
Columbus 64
Dong Ket 64
Seoul 62
Lauterbourg 61
São Paulo 61
Jakarta 55
Vienna 52
Haiphong 50
Helsinki 50
Nanjing 49
Phoenix 45
Moscow 43
Da Nang 41
Montreal 37
Guangzhou 36
Lawrence 35
Warsaw 35
Munich 34
Quận Bình Thạnh 33
Atlanta 31
Johannesburg 31
Turin 31
London 30
Newark 29
Denver 28
Biên Hòa 27
Hyderabad 27
San Diego 26
Altamura 25
Orem 25
Boardman 24
Hải Dương 24
Poplar 23
Rio de Janeiro 22
Nuremberg 21
Zurich 21
Bologna 20
Stockholm 20
Washington 20
Brooklyn 19
Turku 19
Dhaka 18
Amsterdam 17
Can Tho 17
Florence 17
Ha Long 17
Nanchang 17
San Francisco 17
Shenyang 17
Thái Nguyên 17
Baghdad 16
Boston 16
Brussels 16
Mexico City 16
Philadelphia 16
Tokyo 16
Bari 15
Changsha 15
Figino 15
Messina 15
Piscataway 15
Sacramento 15
Andover 14
Genoa 14
Kent 14
Naples 14
Tashkent 14
Totale 11.104
Nome #
Preliminary data of ICV delivery of human Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 1.167
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 823
Mitochondrial and energy metabolism dysfunctions are hallmarks of TDP-43G376D fibroblasts from members of an Amyotrophic Lateral Sclerosis family 419
Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats 412
Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis 407
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 407
Human neural stem cell transplantation in ALS: Initial results from a phase I trial 374
Morphological and metabolic changes in microglia exposed to cadmium: Cues on neurotoxic mechanisms 357
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 356
Production and characterization of human induced pluripotent stem cells (iPSC) CSSi007-A (4383) from Joubert Syndrome 333
Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies 331
A link between genetic disorders and cellular impairment, using human induced pluripotent stem cells to reveal the functional consequences of copy number variations in the central nervous system—a close look at chromosome 15 331
Immortalization of human neural stem cells with the c-myc mutant T58A 324
Generation and characterization of a patient-derived iPSC line, CSSi022-A (15666), with a pathogenic MFN2 mutation causing Charcot-Marie-Tooth disease type 2A 322
Mild hypoxia enhances proliferation and multipotency of human neural stem cells 312
Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy 302
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine 296
Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease 296
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 289
Preliminary data of intracerebroventricular transplantation of human-Neural Stem Cells in a mouse model of Amyotrophic Lateral Sclerosis 287
Production of CSSi013-A (9360) iPSC line from an asymptomatic subject carrying an heterozygous mutation in TDP-43 protein 281
Neural stem cells and human induced pluripotent stem cells to model rare CNS diseases 278
Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage 278
Generation of induced pluripotent stem cells (CSSi017-A)(12862) from an ALS patient carrying a repeat expansion in the C9orf72 gene 277
Generation of an induced pluripotent stem cell line (CSS012-A (7672)) carrying the p.G376D heterozygous mutation in the TARDBP protein 277
Generation of induced pluripotent stem cell line CSSi008-A (4698) from a patient affected by advanced stage of Dentato-Rubral-Pallidoluysian atrophy (DRPLA) 272
Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage 270
Adult stem cell as new advanced therapy for experimental neuropathic pain treatment 269
Production and characterization of human induced pluripotent stem cells (iPSCs) from Joubert Syndrome: CSSi001-A (2850) 269
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. 268
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (Cyno-1) after transplantation 267
Human Fetal Neural Stem Cells for Neurodegenerative Disease Treatment 266
Induced pluripotent stem cell production (CSSi019-A)(14432) from an asymptomatic subject carrying a expansion of C9orf72 gene 265
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression 264
Isolation of neural stem cells from neural tissues using the neurosphere technique 262
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease 261
Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model 260
Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization 257
Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene 251
Unique expression and localization of aquaporin-4 and aquaporin-9 in murine and human neural stem cells and in their glial progeny 251
Exploring the metabolic signature of ALS patients-derived cells 249
Advances in stem cell therapy for amyotrophic lateral sclerosis 247
Retinoic acid-induced 1 gene haploinsufficiency alters lipid metabolism and causes autophagy defects in Smith-Magenis syndrome 246
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 245
Production of an induced pluripotent stem cell line CSSi018-A (14192) from a patient with hypomyelinating leukodystrophy 7 (HLD7) carrying biallelic variants of POLR3A (c.1802 T > A; c.4072G > A) 242
Production and characterization of CSSI003 (2961) human induced pluripotent stem cells (iPSCs) carrying a novel puntiform mutation in RAI1 gene, Causative of Smithâ Magenis syndrome 240
Exploring the metabolic signature of Amyotrophic Lateral Sclerosis patients-derived cells 236
Generation of the CSSi020-A (14437) iPSC line from a patient carrying a copy number variation (CNV) in the 17p11.2 chromosome region 233
Safety and efficacy evaluation of intracerebroventricular human neural stem cell transplantation in SOD1 mice as a novel approach for ALS 228
Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene 226
Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7 220
Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies 214
Generation and characterization of the CSSi021-A (15665) human induced pluripotent stem cell line from a Smith-Magenis syndrome patient with a heterozygous RAI1 mutation 206
Transplanted dopamine neurons derived from primate ES cells preferentially innervate DARPP-32 striatal progenitors within the graft 205
Unraveling the impact of human cerebrospinal fluid on human neural stem cell fate 203
Inorganic mercury changes the fate of murine CNS stem cells 199
INTERROGATING ALS SIGNATURE IN EARLY NEURAL PROGENITOR CELLS: A DIFFERENT PERSPECTIVE 198
Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease 198
The stem cells as a potential treatment for neurodegeneration 190
Culturing and Expansion of “Clinical Grade” Neural Stem Cells from the Fetal Human Central Nervous System 190
INTERROGATING ALS SIGNATURE IN HUMAN INDUCED NEURAL STEM CELLS 185
Brain Organoids to Evaluate Cellular Therapies 158
Uncovering primary cilium defects in Joubert Syndrome using iPSCs derived-Neural Stem Cells 154
Traffic-related diesel pollution particles impair the lysosomal functions of human iPSC-derived microglia 118
Generation and characterization of the hiPSC line CSSi023-A (16154) from a patient with ADOA caused by an OPA1 variant 45
Modelling a TARDBP-ALS Family in iPSC-Derived Neural Stem Cells Uncovers Metabolic and Proliferative Defects 39
Mutant Huntingtin disrupts neurogenic and astroglial programs via the EZH2–Let-7g–LIN28 axis with rescue by epigenetic modulators 33
Interrogating Amyotrophic Lateral Sclerosis Signatures in TDP-43G376D human induced Neural Stem Cells 31
Dissecting TDP-43 loss- and gain-of-function to understand selective motor neuron vulnerability in ALS 27
Totale 18.693
Categoria #
all - tutte 54.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.289


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022387 0 0 0 27 20 40 48 72 30 27 58 65
2022/20231.057 89 269 139 111 93 147 10 51 58 23 39 28
2023/2024909 26 29 56 73 103 188 148 42 68 35 32 109
2024/20253.666 126 195 242 138 183 123 156 110 302 430 251 1.410
2025/20267.078 669 680 547 817 763 357 852 318 588 678 368 441
2026/20271.749 200 440 667 442 0 0 0 0 0 0 0 0
Totale 18.693